The ‘Ensuring Drug Security’ Russian Pharmaceutical Forum, the main business event of the pharmaceutical industry, will be held on 14 June, the opening day of the St. Petersburg International Economic Forum.

To submit an application


To attend the Forum, please:

  1. Sign up for a Roscongress personal account on the official roscongress.org website.
  2. When completing the application, select the ‘SPIEF’
  3. Next, select the ‘SPIEF sideline events participant (14 June, 17 June)’ package.
  4. Next, select the ‘Drug Security Forum’ (14 June).

Once you have registered, your login and password for your Roscongress personal account will be emailed to the address you provide.

If you already have a Roscongress personal account

If you already have a Roscongress personal account, you may apply to participate in the Forum in the ‘Upcoming’ section of your personal account. Your account profile details will be entered in your application automatically.

If you have forgotten your login and password, you can use the login and password recovery function on the Roscongress personal account login page or contact us by email: weboffice@roscongress.org.


More information about the Roscongress personal account and registration procedure for our events available in the video below.

Alla Samoylova, Head of the Federal Service for Surveillance in Healthcare

Timely provision of patients with safe, effective, and quality medication is an urgent matter for the Russian Government, the Russian Ministry of Health, and Roszdravnadzor. Public events where these issues are discussed are always interesting for both the government and the professional community. I am sure that the Drug Security Forum will become a discussion platform, where practical proposals for the development of the pharmaceutical industry will originate and new opportunities to improve the domestic industry for the benefit of Russian patients will be found.

Alexander Petrov, Chairman of Subcommittee on Medicines Circulation, Pharmaceutical and Medical Industry Development, Committee of the State Duma of the Federal Assembly of the Russian Federation on Health Protection

The pandemic posed a serious challenge to the national drug delivery system. However, thanks to the new threat, we were able to come together as never before to respond quickly and find new solutions. Business and the government worked as a single coherent mechanism, and the pharmaceutical industry was almost instantly restructured to work more effectively under the new conditions. This is the first time the Drug Security Forum is taking place, but I am sure that meetings of the expert community on the sidelines of the Forum will become traditional, and the Forum itself will become a key business event of the industry.

Vitaly Omelyanovkiy, Director of the Center for Healthcare Quality Assessment and Control of the Ministry of Health of the Russian Federation

Event formats that bring together representatives of state authorities, business, and professional associations must be used effectively at all stages of drug development. Negotiating process with patients, pharmaceutical industry, and government must be civilized. Decisions we make must be systematic and well thought out. I am sure that within the Drug Security Forum we will be able to outline further effective steps to regulate the national drug supply system.

Yuri Zhulev, Co-chairman of the Russian Union of Patients Public Societies

The disappearance of life-saving drugs from the system is a huge challenge, which we must assess, analyze, and take certain steps to ensure that this does not happen again. In this case, we need to build a quality dialogue with the patient community, the people who are the main beneficiaries of drug security activities. This dialogue should be developed along the following guideline: "patient - patient organization - pharmaceutical manufacturer." In the end, patient organizations must participate in making regulatory decisions. The topic of patient-centred drug provision will be one of the key themes of the Drug Security Forum.

Oleg Yanushevich, Rector, Yevdokimov Moscow State University of Medicine and Dentistry, Russian Ministry of Health

National security is what makes Russia independent from any outside pressure and enables it to develop independently. With people paying 200 million visits to dental clinics each year and more than 5,000 items used in dental practice, it is essential to create a full cycle of import substitution in dentistry to ensure Russian citizens can meet their needs for high-quality and uninterrupted dental treatment.

Sergey Sayganov, Rector, Mechnikov North-Western State Medical University, Russian Ministry of Health

Each year, the ‘Ensuring Drug Security’ Forum demonstrates the need for specialists from the pharmaceutical business, doctors, and healthcare leaders to interact on a single discussion platform. Given the current need for import substitution and the regulation of drug circulation in Russia, documents that govern pharmaceutical and medical activities need to be harmonized. Exchanging opinions and experience as well as discussing controversial issues will help the Russian healthcare industry avoid any unnecessary procedural and regulatory obstacles in the development, research, and use of medicines

Sofia Malyavina, General Director, National Priorities Autonomous Non-Commercial Organization

Healthcare is one of the three most popular topics in terms of the number of hits on the explain.rf and nationalprojects.rf portals. People are paying increased attention to such issues as affordable and high-quality medical care, including drug supply. In order for support measures to be sought-after and meet people’s current demands, regardless of age, individual needs, and geography, the government, society, and medical and business communities need to maintain an open dialogue. The Forum allows for organizing this specific format of interaction.


Russian Minister of Health
Director, Russian Federal Medical-Biological Agency
Director, Federal Service for Surveillance in Healthcare
President, Eurasian Patent Office
Russian Deputy Minister of Health
Acting General Director, Fyodorov Eye Microsurgery Federal State Institution
Director, Federal Centre for the Planning and Organization of Drug Provision to Citizens, Russian Ministry of Health
General Director, National Medical Research Radiological Centre, Russian Ministry of Health
General Director, Centre for Expert Evaluation and Quality Control of Medical Care, Russian Ministry of Health
General Director, Almazov National Medical Research Centre, Russian Ministry of Health
General Director, Endocrinology National Research Centre, Russian Ministry of Health
Chairman, Subcommittee on Drug Circulation and the Development of the Pharmaceutical and Medical Industry, State Duma Committee for Health Protection
Director, Bochkov Research Centre for Medical Genetics
Director, Russian Research Institute of Health, Russian Ministry of Health



With the support of

Subcommittee for drug circulation and the development of the pharmaceutical and medical industries (a body operating under the State Duma of the Russian Federation’s Health Protection Committee).

Organization partner

Программа форума